Global Transcriptome Technology Market Research Report 2025

Publication ID:

PB504258516

Publication Date:

May 2, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Transcriptome Technology was valued at US$ 4215 million in the year 2024 and is projected to reach a revised size of US$ 8139 million by 2031, growing at a CAGR of 10.0% during the forecast period.
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics.
North American market for Transcriptome Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Transcriptome Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Transcriptome Technology in Pharmaceutical and Biotechnology is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Transcriptome Technology include Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Transcriptome Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcriptome Technology.
The Transcriptome Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transcriptome Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transcriptome Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type
PCR
Microarray
Sequencing
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transcriptome Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transcriptome Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PCR
1.2.3 Microarray
1.2.4 Sequencing
1.3 Market by Application
1.3.1 Global Transcriptome Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical and Biotechnology
1.3.3 Academic Research and Government Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transcriptome Technology Market Perspective (2020-2031)
2.2 Global Transcriptome Technology Growth Trends by Region
2.2.1 Global Transcriptome Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Transcriptome Technology Historic Market Size by Region (2020-2025)
2.2.3 Transcriptome Technology Forecasted Market Size by Region (2026-2031)
2.3 Transcriptome Technology Market Dynamics
2.3.1 Transcriptome Technology Industry Trends
2.3.2 Transcriptome Technology Market Drivers
2.3.3 Transcriptome Technology Market Challenges
2.3.4 Transcriptome Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transcriptome Technology Players by Revenue
3.1.1 Global Top Transcriptome Technology Players by Revenue (2020-2025)
3.1.2 Global Transcriptome Technology Revenue Market Share by Players (2020-2025)
3.2 Global Transcriptome Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Transcriptome Technology Revenue
3.4 Global Transcriptome Technology Market Concentration Ratio
3.4.1 Global Transcriptome Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transcriptome Technology Revenue in 2024
3.5 Global Key Players of Transcriptome Technology Head office and Area Served
3.6 Global Key Players of Transcriptome Technology, Product and Application
3.7 Global Key Players of Transcriptome Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transcriptome Technology Breakdown Data by Type
4.1 Global Transcriptome Technology Historic Market Size by Type (2020-2025)
4.2 Global Transcriptome Technology Forecasted Market Size by Type (2026-2031)
5 Transcriptome Technology Breakdown Data by Application
5.1 Global Transcriptome Technology Historic Market Size by Application (2020-2025)
5.2 Global Transcriptome Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Transcriptome Technology Market Size (2020-2031)
6.2 North America Transcriptome Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Transcriptome Technology Market Size by Country (2020-2025)
6.4 North America Transcriptome Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transcriptome Technology Market Size (2020-2031)
7.2 Europe Transcriptome Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Transcriptome Technology Market Size by Country (2020-2025)
7.4 Europe Transcriptome Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transcriptome Technology Market Size (2020-2031)
8.2 Asia-Pacific Transcriptome Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Transcriptome Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific Transcriptome Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transcriptome Technology Market Size (2020-2031)
9.2 Latin America Transcriptome Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Transcriptome Technology Market Size by Country (2020-2025)
9.4 Latin America Transcriptome Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transcriptome Technology Market Size (2020-2031)
10.2 Middle East & Africa Transcriptome Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Transcriptome Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa Transcriptome Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Transcriptome Technology Introduction
11.1.4 Thermo Fisher Scientific Revenue in Transcriptome Technology Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Transcriptome Technology Introduction
11.2.4 Illumina Revenue in Transcriptome Technology Business (2020-2025)
11.2.5 Illumina Recent Development
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Details
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) Transcriptome Technology Introduction
11.3.4 QIAGEN (Exiqon) Revenue in Transcriptome Technology Business (2020-2025)
11.3.5 QIAGEN (Exiqon) Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Transcriptome Technology Introduction
11.4.4 Agilent Technologies Revenue in Transcriptome Technology Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Transcriptome Technology Introduction
11.5.4 Roche Revenue in Transcriptome Technology Business (2020-2025)
11.5.5 Roche Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Transcriptome Technology Introduction
11.6.4 GE Healthcare Revenue in Transcriptome Technology Business (2020-2025)
11.6.5 GE Healthcare Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Transcriptome Technology Introduction
11.7.4 Bio-Rad Laboratories Revenue in Transcriptome Technology Business (2020-2025)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Fluidigm
11.8.1 Fluidigm Company Details
11.8.2 Fluidigm Business Overview
11.8.3 Fluidigm Transcriptome Technology Introduction
11.8.4 Fluidigm Revenue in Transcriptome Technology Business (2020-2025)
11.8.5 Fluidigm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂